Libor Pastika

Libor Pastika

Auto-generated profile, based on publicly available information

Libor Pastika

National Heart and Lung Institute, Imperial College London , Hammersmith Campus, Du Cane Road, London W12 0NN

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2025 in The Lancet Digital Health
Verified
Journal Article
Open access
ASArunashis Sau
Arunashis Sau
ESEwa Sieliwonczyk
Ewa Sieliwonczyk
KPKonstantinos Patlatzoglou
Konstantinos Patlatzoglou
LPLibor Pastika
Libor Pastika
KMKathryn A McGurk
Kathryn A McGurk
Fu Siong NgFu Siong Ng
Fu Siong Ng
Females are typically underserved in cardiovascular medicine. The use of sex as a dichotomous variable for risk stratification fails to capture the heterogeneity of risk within each sex. We aimed to develop an artificial intelligence-enhanced electrocardiography (AI-ECG) model to investigate sex-specific cardiovascular risk. In this retrospective cohort study, we trained a convolutional neural network to classify sex using the 12-lead electrocardiogram (ECG). The Beth Israel Deaconess Medical Center (BIDMC) secondary care dataset, comprising data from individuals who had clinically indicated ECGs performed in a hospital setting in Boston, MA, USA collected between May, 2000, and March, 2023, was the derivation cohort (1 163 401 ECGs). 50% of this dataset was used for model training, 10% for validation, and 40% for testing. External validation was performed using the UK Biobank cohort, comprising data from volunteers aged 40-69 years at the time of enrolment in 2006-10 (42 386 ECGs). We examined the difference between AI-ECG-predicted sex (continuous) and biological sex (dichotomous), termed sex discordance score. AI-ECG accurately identified sex (area under the receiver operating characteristic 0·943 [95% CI 0·942-0·943] for BIDMC and 0·971 [0·969-0·972] for the UK Biobank). In BIDMC outpatients with normal ECGs, an increased sex discordance score was associated with covariate-adjusted increased risk of cardiovascular death in females (hazard ratio [HR] 1·78 [95% CI 1·18-2·70], p=0·006) but not males (1·00 [0·63-1·58], p=0·996). In the UK Biobank cohort, the same pattern was seen (HR 1·33 [95% CI 1·06-1·68] for females, p=0·015; 0·98 [0·80-1·20] for males, p=0·854). Females with a higher sex discordance score were more likely to have future heart failure or myocardial infarction in the BIDMC cohort and had more male cardiac (increased left ventricular mass and chamber volumes) and non-cardiac phenotypes (increased muscle mass and reduced body fat percentage) in both cohorts. Sex discordance score is a novel AI-ECG biomarker capable of identifying females with disproportionately elevated cardiovascular risk. AI-ECG has the potential to identify female patients who could benefit from enhanced risk factor modification or surveillance. British Heart Foundation.

25 June 2024 in npj Digital Medicine
Verified
Journal Article
Open access
PDF file
LPLibor Pastika
Libor Pastika
ASArunashis Sau
Arunashis Sau
KPKonstantinos Patlatzoglou
Konstantinos Patlatzoglou
ESEwa Sieliwonczyk
Ewa Sieliwonczyk
ARAntonio Luiz Ribeiro
Antonio Luiz Ribeiro
Fu Siong NgFu Siong Ng
Fu Siong Ng
The electrocardiogram (ECG) can capture obesity-related cardiac changes. Artificial intelligence-enhanced ECG (AI-ECG) can identify subclinical disease. We trained an AI-ECG model to predict body mass index (BMI) from the ECG alone. Developed from 512,950 12-lead ECGs from the Beth Israel Deaconess Medical Center (BIDMC), a secondary care cohort, and validated on UK Biobank (UKB) (n = 42,386), the model achieved a Pearson correlation coefficient (r) of 0.65 and 0.62, and an R2 of 0.43 and 0.39 in the BIDMC cohort and UK Biobank, respectively for AI-ECG BMI vs. measured BMI. We found delta-BMI, the difference between measured BMI and AI-ECG-predicted BMI (AI-ECG-BMI), to be a biomarker of cardiometabolic health. The top tertile of delta-BMI showed increased risk of future cardiometabolic disease (BIDMC: HR 1.15, p < 0.001; UKB: HR 1.58, p < 0.001) and diabetes mellitus (BIDMC: HR 1.25, p < 0.001; UKB: HR 2.28, p < 0.001) after adjusting for covariates including measured BMI. Significant enhancements in model fit, reclassification and improvements in discriminatory power were observed with the inclusion of delta-BMI in both cohorts. Phenotypic profiling highlighted associations between delta-BMI and cardiometabolic diseases, anthropometric measures of truncal obesity, and pericardial fat mass. Metabolic and proteomic profiling associates delta-BMI positively with valine, lipids in small HDL, syntaxin-3, and carnosine dipeptidase 1, and inversely with glutamine, glycine, colipase, and adiponectin. A genome-wide association study revealed associations with regulators of cardiovascular/metabolic traits, including SCN10A, SCN5A, EXOG and RXRG. In summary, our AI-ECG-BMI model accurately predicts BMI and introduces delta-BMI as a non-invasive biomarker for cardiometabolic risk stratification.

16 July 2025 in European Heart Journal
Verified
Journal Article
Open access
YLYixiu Liang
Yixiu Liang
ASArunashis Sau
Arunashis Sau
BZBoroumand Zeidaabadi
Boroumand Zeidaabadi
JBJoseph Barker
Joseph Barker
KPKonstantinos Patlatzoglou
Konstantinos Patlatzoglou
Fu Siong NgFu Siong Ng
Fu Siong Ng
Background and Aims: Valvular heart disease (VHD) is a significant source of morbidity and mortality, though early intervention can improve outcomes. This study aims to develop artificial intelligence-enhanced electrocardiography (AI-ECG) models to diagnose and predict future moderate or severe regurgitant VHDs (rVHDs), including mitral regurgitation (MR), tricuspid regurgitation (TR), and aortic regurgitation (AR). Methods: The AI-ECG models were developed in a data set of 988 618 ECG and transthoracic echocardiogram pairs from 400 882 patients from Zhongshan Hospital, Shanghai, China. The AI-ECG models used a residual convolutional neural network with a discrete-time survival loss function. External evaluation was performed in outpatients from a secondary care data set from Beth Israel Deaconess Medical Center, Boston, USA, consisting of 34 214 patients with linked echocardiography. Results: In the internal test set, the AI-ECG models accurately predicted future significant MR [C-index 0.774, 95% confidence interval (CI) 0.753–0.792], AR (0.691, 95% CI 0.657–0.720), and TR (0.793, 95% CI 0.777–0.808). In age- and sex-adjusted Cox models, the highest risk quartile had a hazard ratio (HR) of 7.6 (95% CI 5.8–9.9, P < .0001) for risk of future significant MR, compared with the lowest risk quartile. For future AR and TR, the equivalent HRs were 3.8 (95% CI 2.7–5.5) and 9.9 (95% CI 7.5–13.0), respectively. These findings were confirmed in the transnational external test set. Imaging association analyses demonstrated AI-ECG predictions were associated with subclinical chamber remodelling. Conclusions: This study developed AI-ECG models to diagnose and predict rVHDs and validated the models in a transnational and ethnically distinct cohort. The AI-ECG models could be utilized to guide surveillance echocardiography in patients at risk of future rVHDs, to facilitate early detection and intervention.

1 December 2024 in Circulation: Cardiovascular Quality and Outcomes
Verified
Journal Article
Open access
ASArunashis Sau
Arunashis Sau
ARAntônio H Ribeiro
Antônio H Ribeiro
KMKathryn A McGurk
Kathryn A McGurk
LPLibor Pastika
Libor Pastika
Nikesh BajajNikesh Bajaj
Nikesh Bajaj
Fu Siong NgFu Siong Ng
Fu Siong Ng
BACKGROUND: Subtle, prognostically important ECG features may not be apparent to physicians. In the course of supervised machine learning, thousands of ECG features are identified. These are not limited to conventional ECG parameters and morphology. We aimed to investigate whether neural network–derived ECG features could be used to predict future cardiovascular disease and mortality and have phenotypic and genotypic associations. METHODS: We extracted 5120 neural network–derived ECG features from an artificial intelligence–enabled ECG model trained for 6 simple diagnoses and applied unsupervised machine learning to identify 3 phenogroups. Using the identified phenogroups, we externally validated our findings in 5 diverse cohorts from the United States, Brazil, and the United Kingdom. Data were collected between 2000 and 2023. RESULTS: In total, 1 808 584 patients were included in this study. In the derivation cohort, the 3 phenogroups had significantly different mortality profiles. After adjusting for known covariates, phenogroup B had a 20% increase in long-term mortality compared with phenogroup A (hazard ratio, 1.20 [95% CI, 1.17–1.23]; P <0.0001; phenogroup A mortality, 2.2%; phenogroup B mortality, 6.1%). In univariate analyses, we found phenogroup B had a significantly greater risk of mortality in all cohorts (log-rank P <0.01 in all 5 cohorts). Phenome-wide association study showed phenogroup B had a higher rate of future atrial fibrillation (odds ratio, 2.89; P <0.00001), ventricular tachycardia (odds ratio, 2.00; P <0.00001), ischemic heart disease (odds ratio, 1.44; P <0.00001), and cardiomyopathy (odds ratio, 2.04; P <0.00001). A single-trait genome-wide association study yielded 4 loci. SCN10A , SCN5A , and CAV1 have roles in cardiac conduction and arrhythmia. ARHGAP24 does not have a clear cardiac role and may be a novel target. CONCLUSIONS: Neural network–derived ECG features can be used to predict all-cause mortality and future cardiovascular diseases. We have identified biologically plausible and novel phenotypic and genotypic associations that describe mechanisms for the increased risk identified.

25 February 2025 in European Heart Journal - Digital Health
Verified
Journal Article
Open access
KMKrzysztof Macierzanka
Krzysztof Macierzanka
ASArunashis Sau
Arunashis Sau
KPKonstantinos Patlatzoglou
Konstantinos Patlatzoglou
LPLibor Pastika
Libor Pastika
ESEwa Sieliwonczyk
Ewa Sieliwonczyk
Fu Siong NgFu Siong Ng
Fu Siong Ng
Aims: Many research databases with anonymized patient data contain electrocardiograms (ECGs) from which traditional identifiers have been removed. We evaluated the ability of artificial intelligence (AI) methods to determine the similarity between ECGs and assessed whether they have the potential to be misused to re-identify individuals from anonymized datasets. Methods and results: We utilized a convolutional Siamese neural network (SNN) architecture, which derives a Euclidean distance similarity metric between two input ECGs. A secondary care dataset of 864 283 ECGs (72 455 subjects) was used. Siamese neural network-electrocardiogram (SNN-ECG) achieves an accuracy of 91.68% when classifying between 2 689 124 same-subject pairs and 2 689 124 different-subject pairs. This performance increases to 93.61% and 95.97% in outpatient and normal ECG subsets. In a simulated ‘motivated intruder’ test, SNN-ECG can identify individuals from large datasets. In datasets of 100, 1000, 10 000, and 20 000 ECGs, where only one ECG is also from the reference individual, it achieves success rates of 79.2%, 62.6%, 45.0%, and 40.0%, respectively. If this was random, the success would be 1%, 0.1%, 0.01%, and 0.005%, respectively. Additional basic information, like subject sex or age-range, enhances performance further. We also found that, on the subject level, ECG pair similarity is clinically relevant; greater ECG dissimilarity associates with all-cause mortality [hazard ratio, 1.22 (1.21–1.23), P < 0.0001] and is additive to an AI-ECG model trained for mortality prediction. Conclusion: Anonymized ECGs retain information that may facilitate subject re-identification, raising privacy and data protection concerns. However, SNN-ECG models also have positive uses and can enhance risk prediction of cardiovascular disease.

1 July 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
MGMehak Gurnani
Mehak Gurnani
KPKonstantinos Patlatzoglou
Konstantinos Patlatzoglou
JBJoseph Barker
Joseph Barker
DBDerek Bivona
Derek Bivona
LPLibor Pastika
Libor Pastika
Fu Siong NgFu Siong Ng
Fu Siong Ng
Background: Abnormal ventricular depolarization, evident as a broad QRS complex on an ECG, is traditionally categorized into left bundle‐branch block (LBBB) and right bundle‐branch block or nonspecific intraventricular conduction delay. This categorization, although physiologically accurate, may fail to capture the nuances of diseases subtypes. Methods: We used unsupervised machine learning to identify and characterize novel broad QRS phenogroups. First, we trained a variational autoencoder on 1.1 million ECGs and discovered 51 latent features that showed high disentanglement and ECG reconstruction accuracy. We then extracted these features from 42 538 ECGs with QRS durations >120 milliseconds and employed a reversed graph embedding method to model population heterogeneity as a tree structure with different branches representing phenogroups. Results: Six phenogroups were identified, including phenogroups of right bundle‐branch block and LBBB with varying risk of cardiovascular disease and mortality. The higher risk right bundle‐branch block phenogroup exhibited increased risk of cardiovascular death (adjusted hazard ratio [aHR], 1.46 [1.30–1.63], P <0.0001) and all‐cause mortality (aHR, 1.24 [1.16–1.33], P <0.0001) compared with the baseline phenogroup. Within LBBB ECGs, tree position predicted future cardiovascular disease risk differentially. Additionally, for subjects with LBBB undergoing cardiac resynchronization therapy, tree position predicted cardiac resynchronization therapy response independent of covariates, including QRS duration (adjusted odds ratio [aOR], 0.47 [0.25–0.86], P <0.05). Conclusions: Our findings challenge the current paradigm, highlighting the potential for these phenogroups to enhance cardiac resynchronization therapy patient selection for subjects with LBBB and guide investigation and follow‐up strategies for subjects with higher risk right bundle‐branch block.